OKYO Pharma Limited (OKYO)
1.03
0.01 (0.98%)
At close: Jan 28, 2025, 2:54 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -16.83M | -13.28M | -6.22M | -3.38M | -1.62M | -4.90M | -28.27M | -241.93K | -820.17K | -8.26M | -13.93M | -4.66M | -5.70M | -1.76M | 12.67M | 13.95M | -3.32M |
| Depreciation & Amortization | 3.87K | 3.80K | 2.33K | 13.11K | 5.98K | 217.82 | n/a | n/a | n/a | n/a | 103.44K | 24.44K | 19.61K | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.12M | 1.27M | 1.72M | 544.39K | 36.34K | 50.53K | 4.24K | 18.37K | 99.20K | n/a | 1.41M | 1.33M | 825.62K | 155.88K | 180.84K | 114.61K | 2.39M |
| Other Working Capital | -570.08K | 982.04K | -753.25K | 1.05M | 308.88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | 3.54M | 114.99K | 61.72K | 83.00K | 42.84K | 2.69M | 26.63M | -0.00 | -39.25K | 6.91M | 9.02M | -93.22K | -20.67K | 310.15K | -13.72M | -14.32M | 345.28K |
| Deferred Income Tax | n/a | 250.34K | -9.41K | 92.95K | 146.58K | -1.17K | n/a | n/a | n/a | n/a | 9.02M | -0.00 | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.67M | 3.95M | -1.02M | 1.04M | 186.53K | 176.81K | 35.72K | -427.71K | 109.34K | -74.71K | -55.60K | -429.44K | 203.67K | -17.68K | -7.54K | 22.92K | 75.41K |
| Operating Cash Flow | -9.49M | -7.70M | -5.47M | -1.60M | -1.20M | -1.99M | -1.59M | -651.27K | -650.88K | -1.42M | -3.45M | -3.82M | -4.67M | -1.31M | -878.61K | -226.35K | -513.95K |
| Capital Expenditures | -3 | -5.92K | -1.67K | -6.94K | n/a | -1.32K | n/a | -375.39K | -406.05K | -2.76M | -10.65M | -7.18M | -3.51M | n/a | n/a | -717.73K | -2.82M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -11.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -507.81K | -4.00M | -10.56M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.51M | 24.83M | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | -11.17K | -132.67K | n/a | n/a | -373.60K | -334.72K | -2.75M | -10.33M | -6.76M | -3.67M | 141.41K | -0.00 | n/a | n/a |
| Investing Cash Flow | n/a | -5.92K | -1.67K | -18.11K | -132.67K | -1.32K | n/a | -375.39K | -335.18K | -2.76M | -10.59M | -7.18M | -4.12M | 29.14M | 20.82M | -11.27M | -2.82M |
| Debt Repayment | n/a | 2.00M | n/a | 7.58M | n/a | n/a | n/a | 4.42K | 12.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40.74M | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 2.15M | 15.87K | -27.33K | n/a | n/a | n/a | n/a | 131.98K | 221.55K | 162.37K | 847.43K | 0.72 | n/a | n/a | n/a |
| Financial Cash Flow | 6.21M | 9.32M | 2.15M | 7.83M | 963.31K | n/a | n/a | 4.42K | 12.36K | 370.51K | 10.43M | 8.69M | 9.25M | -40.17M | 1.03M | 3.91M | 21.30M |
| Net Cash Flow | -3.22M | 1.34M | -4.19M | 6.65M | -392.13K | -1.99M | -1.59M | -651.27K | -1.15M | -4.05M | -3.88M | -1.83M | 1.02M | -12.34M | 20.98M | -7.59M | 17.97M |
| Free Cash Flow | -9.49M | -7.70M | -5.47M | -1.61M | -1.20M | -1.99M | -1.59M | -1.03M | -1.06M | -4.18M | -14.10M | -11.00M | -8.18M | -1.31M | -878.61K | -944.09K | -3.33M |